# Neostigmine Methylsulfate

NDC: 76045-383
Generic name: Neostigmine Methylsulfate
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180918

FDA application: NDA203629

## Active ingredients

- NEOSTIGMINE METHYLSULFATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76045-383"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76045-383
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0b509c3-8dc8-48cc-b7a8-16b93ad706c6